Use access key #2 to skip to page content.
$47.13 4.35 (10.17%)
10/13/2008 4:00 PM

Biogen Idec, Inc. (BIIB)

CAPS Rating:
****

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

View Ticker Page (BIIB)

Results 51 - 60 of 78 : « Previous   678

Recs

0

Avatar chrisccarlson (89.79) Submitted: 11/03/06 10:13 PM : Outperform Start Price: $48.01 BIIB Score: 24.12

If you like biotech this is your bluechip

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar rowder (< 20) Submitted: 10/19/06 6:43 PM : Outperform Start Price: $45.89 BIIB Score: 28.16

Tysabi will carry them up.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar EmpireTreb (93.84) Submitted: 10/19/06 2:23 AM : Outperform Start Price: $45.71 BIIB Score: 28.25

This company's aggressive pursuit of MS drugs/therapies is impressive to me. Also, the duties to shareholders in looking for the next best acquisition bodes well for their future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar cnbr1 (38.53) Submitted: 10/04/06 9:39 AM : Outperform Start Price: $44.66 BIIB Score: 28.78

Tysabri traction in the US and EU.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar samwel (43.16) Submitted: 9/22/06 1:55 AM : Outperform Start Price: $43.75 BIIB Score: 30.17

Will develope product to market or bought out

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar fsc137 (96.98) Submitted: 9/18/06 9:05 PM : Outperform Start Price: $43.50 BIIB Score: 31.29

Things seem to be looking up after a few hard years, and management is doing its job.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar tecmo (56.94) Submitted: 9/05/06 7:33 PM : Outperform Start Price: $44.68 BIIB Score: 28.04

Should hit $55-$60 by end of 2007. EPS of $2.40 / share in 2007 would mean a PE under 25

Report this Post Replies: 5 | Reply | Permalink

Recs

0

Avatar stanhutchings (< 20) Submitted: 8/26/06 12:54 AM : Outperform Start Price: $44.18 BIIB Score: 28.01

biotech pharma will be higher demand

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar gordonsgold (94.68) Submitted: 8/22/06 8:30 PM : Outperform Start Price: $42.75 BIIB Score: 31.75

Leader in oncology drugs. Recent huge set back caused by withdrawl of important drug, however, has gained back most of the loss. The drug to be re-introduced to the market.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar nickysone (< 20) Submitted: 4/08/07 7:59 AM : Outperform Start Price: $44.86 BIIB Score: 34.33

healhtcare stocks have been trailing the markets this was once a 72.00dollar stock but high pe,

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners